Opportunities Preloader

Please Wait.....

Report

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2030

Market Report I 2025-04-28 I 377 Pages I MarketsandMarkets

The global live cell imaging market is projected to reach USD 4.75 billion in 2030 from USD 3.13 billion in 2025, growing at a CAGR of 8.68% during the forecast period. Ongoing advancements in imaging technologies, along with the rising cancer cases in the world, are factors supporting the growth of the market. Moreover, the availability of funds and grants for cellular biology research and the growing adoption of HCS techniques for drug discovery and research is increasing the demand for live cell imaging products and consumables, supporting the growth of the market. Key players are expanding their reach in emerging markets to grab new growth opportunities in the field of live cell imaging; however, this expansion is restricted due to the high cost of live cell imaging instruments, making these products inaccessible to small academic institutes and pharmaceutical companies.
The market for live cell imaging and analysis software is expected to witness the highest growth within the offerings segment during the forecast period.
The live cell imaging software market is expected to witness the highest growth during the forecast period within the offering segment. This high growth can be attributed to the growing demand for advanced data analysis, automation, and AI integration in cellular research. As imaging technologies become more advanced, researchers require powerful software tools to manage large volumes of complex image data, perform real-time analysis, and extract meaningful biological insights. The growing adoption of high-content screening, 3D imaging, and time-lapse microscopy further fuels the need for intelligent software capable of handling multi-dimensional datasets. In addition, the integration of machine learning and deep learning algorithms into imaging software is enabling faster and more accurate cell segmentation, tracking, and phenotyping, making these tools essential in drug discovery, cancer research, and regenerative medicine.
The pharmaceutical & biotechnology companies end user segment held the largest market share in the live cell imaging market, by end user, during the forecast period.
Pharmaceutical & biotechnology companies held the largest share of the live cell imaging market by end users in 2024. This large share can be attributed to the increasing demand for advanced imaging technologies in drug discovery, cell biology research, and personalized medicine. These companies heavily rely on live cell imaging to observe cellular behaviors, study disease mechanisms, and evaluate the effects of potential drug candidates in real time. The rise in the prevalence of chronic diseases and the growing need for precise therapies further fuel the adoption of live cell imaging technologies in these sectors. This trend is expected to continue during the forecast period of 2025-2030, driven by ongoing innovations in imaging technologies, the need for faster and more accurate drug development, and the growing importance of cellular research in therapeutic development.
Asia Pacific is expected to be the fastest-growing region in the live cell imaging market.
Asia Pacific is the fastest-growing region in the live cell imaging market, having the highest CAGR during the forecast period of 2025-2030. This growth is driven by increased investment in the healthcare and biotechnology sectors, along with the rising demand for advanced imaging technologies. China, Japan, and India are increasing their research and development activities, particularly in drug discovery and regenerative medicine, which require advanced imaging techniques. Additionally, government support for scientific research and the expanding focus on personalized medicine are key factors fueling this market growth in the region.

The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24%
- By Designation: (Managers)- 45%, (CXOs, Directors)- 30%, and (Executives)- 25%
- By Region: North America- 40%, Europe- 25%, Asia Pacific- 20%, Rest of the World- 15%
List of Companies Profiled in the Report:
- Danaher (US)
- Zeiss Group (Germany)
- Nikon Corporation (Japan)
- Evident (Japan)
- Revvity (US)
- Sartorius AG (Germany)
- Agilent Technologies, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Nanoentek (Korea)
- Bruker (US)
- BD (US)
- Merck KGaA (Germany)
- Bio-Rad Laboratories, Inc. (US)
- Tecan Trading AG (Switzerland)
- Corning Incorporated (US)
- Sysmex Corporation (Japan)
- Blue-Ray Biotech Corp. (Taiwan)
- Curiosis Inc. (South Korea)
- CYTENA GmbH (Germany)
- Abberior Instruments America LLC (Germany)
- Phase Holographic Imaging PHI AB (Sweden)
- Aligned Genetics (South Korea)
- Cherry Biotech (France)
- Nanolive SA (Switzerland)
- CytoTronics (US)
- Etaluma, Inc. (US)
- Axion BioSystems, Inc (US)
- TissueGnostics GmbH (Austria)
Research Coverage:
This report provides a detailed picture of the global live cell imaging market. It aims to estimate the size and future growth potential of the market across different segments such as the offering, technology, application, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the live cell imaging market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services, key strategies, partnerships, agreements, product and service launches, mergers and acquisitions, and recent developments associated with the live cell imaging market. Competitive analysis of upcoming startups in the live cell imaging market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall live cell imaging market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, Growing availability of funds for research, advancement in imaging technology), restraints (High cost of high-content screening systems), opportunities (increasing adoption of live cell imaging technologies in emerging markets, and application of HCS in personalized medicine), and challenges (maintaining cell viability and cellular environment in cell cultures, and image analysis and data management) influencing the growth of the live cell imaging market
- Product Development/Innovation: Detailed insight into newly launched products & services and technological assessment of the live cell imaging market
- Market Development: Comprehensive information about lucrative markets - the report analyses the live cell imaging market across varied regions.
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the live cell imaging market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and products and service offerings of leading players Danaher (US), Zeiss Group (Germany), Nikon Corporation (Japan), Evident (Japan), Revvity (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Nanoentek (Korea), Bruker (US), BD (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Tecan Trading AG (Switzerland), Corning Incorporated (US), Sysmex Corporation (Japan), Blue-Ray Biotech Corp. (Taiwan), Curiosis Inc. (South Korea), CYTENA GmbH (Germany), Abberior Instruments America LLC (Germany), Phase Holographic Imaging PHI AB (Sweden), Aligned Genetics (South Korea), Cherry Biotech (France), Nanolive SA (Switzerland), CytoTronics (US), Etaluma, Inc. (US), Axion BioSystems, Inc (US), and TissueGnostics GmbH (Austria) among others in the market.

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 36
1.3.2 INCLUSIONS AND EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.4 CURRENCY CONSIDERED 38
1.5 STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.1.1 SECONDARY DATA 40
2.1.2 PRIMARY DATA 41
2.2 MARKET SIZE ESTIMATION 43
2.2.1 INSIGHTS FROM PRIMARIES 45
2.2.2 TOP-DOWN APPROACH 46
2.3 GROWTH RATE FORECAST 47
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 49
2.5 RESEARCH ASSUMPTIONS 50
2.6 RESEARCH LIMITATIONS 50
2.7 RISK ASSESSMENT 51
3 EXECUTIVE SUMMARY 52
4 PREMIUM INSIGHTS 56
4.1 LIVE CELL IMAGING MARKET OVERVIEW 56
4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING AND COUNTRY, 2024 57
4.3 LIVE CELL IMAGING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 58
4.4 LIVE CELL IMAGING MARKET, BY END USER, 2024 58
4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
?
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
5.2.1 DRIVERS 61
5.2.1.1 Growing adoption of high-content screening techniques in drug discovery 61
5.2.1.2 Rising incidence of cancer 62
5.2.1.3 Growing availability of research funds 63
5.2.1.4 Advancements in imaging technology 65
5.2.2 RESTRAINTS 66
5.2.2.1 Expensive high-content screening systems 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Increasing adoption of live cell imaging technologies in emerging markets 66
5.2.3.2 Growing applications of live cell imaging in personalized medicine 67
5.2.4 CHALLENGES 67
5.2.4.1 Maintenance of cell viability and cellular environment in cell cultures 67
5.2.4.2 Image analysis and data management 67
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68
5.4 PRICING ANALYSIS 68
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 69
5.4.2 AVERAGE SELLING PRICE, BY REGION 71
5.5 VALUE CHAIN ANALYSIS 73
5.6 ECOSYSTEM ANALYSIS 74
5.7 INVESTMENT AND FUNDING ACTIVITY 76
5.8 TECHNOLOGY ANALYSIS 77
5.8.1 KEY TECHNOLOGIES 77
5.8.1.1 Fluorescence microscopy 77
5.8.1.2 Confocal microscopy 77
5.8.1.3 Super-resolution microscopy 77
5.8.1.4 Forster resonance energy transfer 78
5.8.1.5 Fluorescence recovery after photobleaching 78
5.8.2 COMPLEMENTARY TECHNOLOGIES 78
5.8.2.1 Image analysis software 78
5.8.2.2 Microfluidics 79
5.8.2.3 Optogenetics 79
5.8.2.4 Multiphoton microscopy 79
5.8.3 ADJACENT TECHNOLOGIES 80
5.8.3.1 Fixed cell imaging 80
5.9 PATENT ANALYSIS 80
?
5.10 TRADE DATA ANALYSIS 84
5.10.1 IMPORT DATA FOR HS CODE 901120 84
5.10.2 EXPORT DATA FOR HS CODE 901120 85
5.11 KEY CONFERENCES AND EVENTS, 2025-2026 86
5.12 REGULATORY LANDSCAPE 87
5.12.1 REGULATORY FRAMEWORK 87
5.12.1.1 North America 87
5.12.1.1.1 US 87
5.12.1.1.2 Canada 88
5.12.1.2 Europe 88
5.12.1.2.1 UK 88
5.12.1.2.2 European Union 88
5.12.1.3 Asia Pacific 89
5.12.1.3.1 Japan 89
5.12.1.3.2 South Korea 89
5.12.1.3.3 China 89
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
5.13 PORTER'S FIVE FORCES ANALYSIS 91
5.13.1 THREAT FROM NEW ENTRANTS 92
5.13.2 THREAT FROM SUBSTITUTES 93
5.13.3 BARGAINING POWER OF SUPPLIERS 93
5.13.4 BARGAINING POWER OF BUYERS 93
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 93
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 94
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
5.14.2 BUYING CRITERIA 95
5.15 IMPACT OF AI/GENERATIVE AI ON LIVE CELL IMAGING MARKET 96
5.15.1 INTRODUCTION 96
5.15.2 KEY COMPANIES IMPLEMENTING AI 97
5.15.3 AI USE CASES 98
5.15.4 FUTURE OF AI IN LIVE CELL IMAGING ECOSYSTEM 98
5.16 IMPACT OF 2025 US TARIFF ON LIVE CELL IMAGING MARKET 99
5.16.1 INTRODUCTION 99
5.16.2 KEY TARIFF RATES 99
5.16.3 PRICE IMPACT ANALYSIS 101
5.16.4 IMPACT ON COUNTRY/REGION 101
5.16.4.1 US 101
5.16.4.2 Europe 102
5.16.4.3 Asia Pacific 103
?
5.16.5 IMPACT ON END-USE INDUSTRIES 103
5.16.5.1 Pharmaceutical & biotech companies 104
5.16.5.2 Academic & research institutes 104
5.16.5.3 Contract research organizations 105
6 LIVE CELL IMAGING MARKET, BY OFFERING 106
6.1 INTRODUCTION 107
6.2 PRODUCTS 107
6.2.1 INSTRUMENTS 107
6.2.1.1 Microscopes 112
6.2.1.1.1 Ongoing technological advancements in microscopes to support growth 112
6.2.1.2 Cell imaging systems 116
6.2.1.2.1 Seamless integration and workflow efficiency of standalone systems to boost market 116
6.2.1.3 Cell analyzers 120
6.2.1.3.1 Accuracy and reproducibility of cell analyzers to encourage growth 120
6.2.1.4 Accessories 123
6.2.1.4.1 Increasing demand for live cell imaging in life science research to accelerate growth 123
6.2.2 CONSUMABLES 127
6.2.2.1 Reagents 130
6.2.2.1.1 Widespread usage of reagents in life science research to foster growth 130
6.2.2.2 Assay kits 134
6.2.2.2.1 Higher customer convenience and time-saving solutions to amplify growth 134
6.2.2.3 Media 138
6.2.2.3.1 Increasing investments in cell-based research to intensify growth 138
6.2.2.4 Other consumables 141
6.3 SOFTWARE 145
6.3.1 INCREASING ADVANCEMENTS IN IMAGE ACQUISITION TO SUPPORT GROWTH 145
6.4 SERVICES 149
6.4.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO FUEL MARKET 149
7 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 152
7.1 INTRODUCTION 153
7.2 TIME-LAPSE MICROSCOPY 153
7.2.1 GROWING DEMAND FOR HIGH CONTENT AND HIGH THROUGHPUT ANALYSIS IN PRECLINICAL STUDIES TO DRIVE MARKET 153
?
7.3 FLUORESCENCE RESONANCE ENERGY TRANSFER 157
7.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST MARKET 157
7.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING 160
7.4.1 INCREASING ADVANCEMENTS IN FLUORESCENT PROTEINS TO SPUR GROWTH 160
7.5 HIGH-CONTENT SCREENING 164
7.5.1 GROWING FOCUS ON DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE MARKET 164
7.6 OTHER TECHNOLOGIES 167
8 LIVE CELL IMAGING MARKET, BY APPLICATION 171
8.1 INTRODUCTION 172
8.2 CELL BIOLOGY RESEARCH 172
8.2.1 INCREASING FOCUS ON DISEASE RESEARCH TO SUPPORT GROWTH 172
8.3 DRUG DISCOVERY 176
8.3.1 GROWING USE OF HIGH-CONTENT SCREENING CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO BOOST MARKET 176
8.4 STEM CELL RESEARCH 179
8.4.1 INCREASING FOCUS ON REGENERATIVE MEDICINE TO EXPEDITE GROWTH 179
8.5 DEVELOPMENTAL BIOLOGY 183
8.5.1 RISING INTEREST IN ORGANOGENESIS AND TISSUE MORPHOGENESIS TO PROMOTE GROWTH 183
9 LIVE CELL IMAGING MARKET, BY END USER 187
9.1 INTRODUCTION 188
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 188
9.2.1 INCREASING R&D ACTIVITIES TO DEVELOP NEW DRUGS TO SUPPORT GROWTH 188
9.3 ACADEMIC & RESEARCH INSTITUTES 192
9.3.1 RISING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO AID GROWTH 192
9.4 CONTRACT RESEARCH ORGANIZATIONS 195
9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE MARKET 195
10 LIVE CELL IMAGING MARKET, BY REGION 199
10.1 INTRODUCTION 200
10.2 NORTH AMERICA 200
10.2.1 MACROECONOMIC ANALYSIS FOR NORTH AMERICA 201
10.2.2 US 205
10.2.2.1 Presence of major players and increasing investments in life science research to sustain growth 205
10.2.3 CANADA 208
10.2.3.1 Government initiatives to promote research to aid growth 208
10.3 EUROPE 211
10.3.1 MACROECONOMIC ANALYSIS FOR EUROPE 212
10.3.2 GERMANY 215
10.3.2.1 Presence of large number of academic research institutes to boost market 215
10.3.3 UK 218
10.3.3.1 Investments by pharmaceutical sponsors for drug discovery services to foster market 218
10.3.4 FRANCE 220
10.3.4.1 Booming pharmaceutical manufacturing industry to drive market growth 220
10.3.5 ITALY 223
10.3.5.1 Strong research tradition, government funding, and collaborative research networks to fuel growth 223
10.3.6 SPAIN 226
10.3.6.1 Rising R&D expenditure to boost market 226
10.3.7 REST OF EUROPE 228
10.4 ASIA PACIFIC 232
10.4.1 MACROECONOMIC ANALYSIS FOR ASIA PACIFIC 232
10.4.2 CHINA 237
10.4.2.1 Low manufacturing cost and surge in research & development investments to spur growth 237
10.4.3 JAPAN 240
10.4.3.1 Presence of large geriatric population and increasing research activities to bolster growth 240
10.4.4 INDIA 243
10.4.4.1 Growing pharmaceutical industry to propel market 243
10.4.5 SOUTH KOREA 246
10.4.5.1 Ongoing collaborations and research initiatives among market players to encourage growth 246
10.4.6 AUSTRALIA 249
10.4.6.1 Robust healthcare infrastructure to facilitate growth 249
10.4.7 REST OF ASIA PACIFIC 252
10.5 LATIN AMERICA 256
10.5.1 MACROECONOMIC ANALYSIS FOR LATIN AMERICA 256
10.5.2 BRAZIL 260
10.5.2.1 Growing focus on biotechnology and biomedical innovations to drive market 260
10.5.3 MEXICO 262
10.5.3.1 Low manufacturing cost and large population to support growth 262
10.5.4 REST OF LATIN AMERICA 265
?
10.6 MIDDLE EAST 268
10.6.1 MACROECONOMIC ANALYSIS FOR MIDDLE EAST 268
10.6.2 GCC COUNTRIES 272
10.6.2.1 Saudi Arabia 275
10.6.2.1.1 Increasing life science research funding to aid growth 275
10.6.2.2 UAE 278
10.6.2.2.1 Presence of research institutes supporting live cell imaging studies to foster growth 278
10.6.2.3 Rest of GCC Countries 280
10.6.3 REST OF MIDDLE EAST 283
10.7 AFRICA 286
10.7.1 GOVERNMENT INITIATIVES TO CONTRIBUTE TO GROWTH 286
10.7.2 MACROECONOMIC ANALYSIS FOR AFRICA 286
11 COMPETITIVE LANDSCAPE 290
11.1 INTRODUCTION 290
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 290
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LIVE CELL IMAGING MARKET 291
11.3 REVENUE ANALYSIS, 2022-2024 293
11.4 MARKET SHARE ANALYSIS, 2024 294
11.5 COMPANY VALUATION AND FINANCIAL METRICS 297
11.6 BRAND/PRODUCT COMPARISON 298
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 299
11.7.1 STARS 299
11.7.2 EMERGING LEADERS 299
11.7.3 PERVASIVE PLAYERS 299
11.7.4 PARTICIPANTS 300
11.8 COMPANY FOOTPRINT, KEY PLAYERS, 2024 301
11.8.1 COMPANY FOOTPRINT 301
11.8.2 REGION FOOTPRINT 302
11.8.3 OFFERING FOOTPRINT 303
11.8.4 APPLICATION FOOTPRINT 305
11.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 306
11.9.1 PROGRESSIVE COMPANIES 306
11.9.2 RESPONSIVE COMPANIES 306
11.9.3 DYNAMIC COMPANIES 306
11.9.4 STARTING BLOCKS 306
11.10 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 308
11.10.1 DETAILED LIST OF KEY STARTUPS/SMES 308
11.10.2 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 309
?
11.11 COMPETITIVE SCENARIO 310
11.11.1 PRODUCT LAUNCHES AND UPGRADES 310
11.11.2 DEALS 311
11.11.3 EXPANSIONS 312
12 COMPANY PROFILE 313
12.1 KEY PLAYERS 313
12.1.1 DANAHER 313
12.1.1.1 Business overview 313
12.1.1.2 Products offered 314
12.1.1.3 Recent developments 316
12.1.1.3.1 Product launches and upgrades 316
12.1.1.3.2 Deals 316
12.1.1.4 MnM view 317
12.1.1.4.1 Key strengths 317
12.1.1.4.2 Strategic choices 317
12.1.1.4.3 Weaknesses and competitive threats 317
12.1.2 ZEISS GROUP 318
12.1.2.1 Business overview 318
12.1.2.2 Products offered 319
12.1.2.3 Recent developments 320
12.1.2.3.1 Product launches and upgrades 320
12.1.2.3.2 Deals 321
12.1.2.3.3 Expansions 321
12.1.2.4 MnM view 321
12.1.2.4.1 Key strengths 321
12.1.2.4.2 Strategic choices 322
12.1.2.4.3 Weaknesses and competitive threats 322
12.1.3 THERMO FISHER SCIENTIFIC INC. 323
12.1.3.1 Business overview 323
12.1.3.2 Products offered 324
12.1.3.3 Recent developments 325
12.1.3.3.1 Deals 325
12.1.3.4 MnM view 326
12.1.3.4.1 Key strengths 326
12.1.3.4.2 Strategic choices 326
12.1.3.4.3 Weaknesses and competitive threats 326
12.1.4 REVVITY 327
12.1.4.1 Business overview 327
12.1.4.2 Products offered 328
12.1.4.3 Recent developments 329
12.1.4.3.1 Product launches and upgrades 329
12.1.4.4 MnM view 330
12.1.4.4.1 Key strengths 330
12.1.4.4.2 Strategic choices 330
12.1.4.4.3 Weaknesses and competitive threats 330
12.1.5 SARTORIUS AG 331
12.1.5.1 Business overview 331
12.1.5.2 Products offered 332
12.1.5.3 Recent developments 333
12.1.5.3.1 Deals 333
12.1.5.4 MnM view 333
12.1.5.4.1 Key strength 333
12.1.5.4.2 Strategic choices 333
12.1.5.4.3 Weaknesses and competitive threats 333
12.1.6 NIKON CORPORATION 334
12.1.6.1 Business overview 334
12.1.6.2 Products offered 335
12.1.6.3 Recent developments 336
12.1.6.3.1 Expansions 336
12.1.7 EVIDENT 337
12.1.7.1 Business overview 337
12.1.7.2 Products offered 337
12.1.7.3 Recent developments 338
12.1.7.3.1 Product launches and upgrades 338
12.1.8 AGILENT TECHNOLOGIES, INC. 339
12.1.8.1 Business overview 339
12.1.8.2 Products offered 340
12.1.8.3 Recent developments 342
12.1.8.3.1 Product launches and upgrades 342
12.1.9 NANOENTEK 343
12.1.9.1 Business overview 343
12.1.9.2 Products offered 343
12.1.10 BRUKER 344
12.1.10.1 Business overview 344
12.1.10.2 Products offered 345
12.1.10.3 Recent developments 346
12.1.10.3.1 Deals 346
12.1.11 BD 347
12.1.11.1 Business overview 347
12.1.11.2 Products offered 348
12.1.12 MERCK KGAA 349
12.1.12.1 Business overview 349
12.1.12.2 Products offered 351
12.1.13 BIO-RAD LABORATORIES, INC. 352
12.1.13.1 Business overview 352
12.1.13.2 Products offered 353
12.1.14 TECAN TRADING AG 354
12.1.14.1 Business overview 354
12.1.15 SYSMEX CORPORATION 356
12.1.15.1 Business overview 356
12.1.15.2 Products offered 357
12.1.16 CORNING INCORPORATED 358
12.1.16.1 Business overview 358
12.1.16.2 Products offered 359
12.2 OTHER PLAYERS 360
12.2.1 AXION BIOSYSTEMS, INC. 360
12.2.2 BLUE-RAY BIOTECH CORP. 361
12.2.3 CURIOSIS INC. 361
12.2.4 CYTENA GMBH 362
12.2.5 ABBERIOR GMBH 363
12.2.6 PHASE HOLOGRAPHIC IMAGING PHI AB 364
12.2.7 ALIGNED GENETICS INC. 365
12.2.8 CHERRY BIOTECH 365
12.2.9 NANOLIVE SA 366
12.2.10 CYTOTRONICS 367
12.2.11 ETALUMA, INC. 368
12.2.12 TISSUEGNOSTICS GMBH 369
13 APPENDIX 370
13.1 DISCUSSION GUIDE 370
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 373
13.3 CUSTOMIZATION OPTIONS 375
13.4 RELATED REPORTS 375
13.5 AUTHOR DETAILS 376

TABLE 1 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 61
TABLE 2 ESTIMATED NEW CANCER CASES IN US, 2025 62
TABLE 3 AVERAGE SELLING PRICE TREND OF LIVE CELL IMAGING PRODUCTS,
BY KEY PLAYER, 2022-2024 69
TABLE 4 AVERAGE SELLING PRICE, BY REGION, 2024 72
TABLE 5 LIVE CELL IMAGING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 75
TABLE 6 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014-2025 80
TABLE 7 LIVE CELL IMAGING MARKET: PATENT ANALYSIS, 2024 82
TABLE 8 IMPORT DATA FOR LIVE CELL IMAGING PRODUCTS (HS CODE 901120),
BY COUNTRY, 2020-2024 (USD THOUSAND) 84
TABLE 9 EXPORT DATA FOR HS CODE 901120, BY COUNTRY,
2020-2024 (USD THOUSAND) 85
TABLE 10 LIVE CELL IMAGING MARKET: KEY CONFERENCES AND EVENTS, 2025-2026 86
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 15 LIVE CELL IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS 92
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 94
TABLE 17 BUYING CRITERIA, BY END USER 95
TABLE 18 US ADJUSTED RECIPROCAL TARIFF RATES 99
TABLE 19 LIVE CELL IMAGING PRODUCT-RELATED TARIFF REVISION 100
TABLE 20 IMPACT OF US TARIFF ON END-USE APPLICATIONS OF LIVE CELL IMAGING PRODUCTS 103
TABLE 21 LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 107
TABLE 22 INSTRUMENTS OFFERED BY KEY MARKET PLAYERS 108
TABLE 23 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION,
2023-2030 (USD MILLION) 109
TABLE 24 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 109
TABLE 25 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 110
TABLE 26 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 110
TABLE 27 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENT MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 111
TABLE 28 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION,
2023-2030 (USD MILLION) 111
TABLE 29 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 111
TABLE 30 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 112
TABLE 31 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2023-2030 (USD MILLION) 113
TABLE 32 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION) 113
TABLE 33 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES,
BY COUNTRY, 2023-2030 (USD MILLION) 114
TABLE 34 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES,
BY COUNTRY, 2023-2030 (USD MILLION) 114
TABLE 35 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION) 115
TABLE 36 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2023-2030 (USD MILLION) 115
TABLE 37 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION) 115
TABLE 38 CELL IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 116
TABLE 39 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS,
BY REGION, 2023-2030 (USD MILLION) 117
TABLE 40 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 117
TABLE 41 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 118
TABLE 42 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 118
TABLE 43 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 119
TABLE 44 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY REGION, 2023-2030 (USD MILLION) 119
TABLE 45 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION) 119
TABLE 46 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS 120
TABLE 47 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2023-2030 (USD MILLION) 120
TABLE 48 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION) 121
TABLE 49 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS,
BY COUNTRY, 2023-2030 (USD MILLION) 121
TABLE 50 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION) 122
TABLE 51 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION) 122
TABLE 52 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2023-2030 (USD MILLION) 122
TABLE 53 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION) 123
TABLE 54 ACCESSORIES OFFERED BY KEY MARKET PLAYERS 123
TABLE 55 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2023-2030 (USD MILLION) 124
TABLE 56 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION) 124
TABLE 57 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 125
TABLE 58 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 125
TABLE 59 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION) 126
TABLE 60 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENT MARKET FOR ACCESSORIES,
BY REGION, 2023-2030 (USD MILLION) 126
TABLE 61 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENT MARKET FOR ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION) 126
TABLE 62 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION,
2023-2030 (USD MILLION) 127
TABLE 63 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 127
TABLE 64 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 128
TABLE 65 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 128
TABLE 66 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 129
TABLE 67 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION,
2023-2030 (USD MILLION) 129
TABLE 68 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 129
TABLE 69 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 130
TABLE 70 REAGENTS OFFERED BY KEY MARKET PLAYERS 131
TABLE 71 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION,
2023-2030 (USD MILLION) 131
TABLE 72 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 73 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 74 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 133
TABLE 75 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 133
TABLE 76 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY REGION, 2023-2030 (USD MILLION) 133
TABLE 77 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 134
TABLE 78 ASSAY KITS OFFERED BY KEY MARKET PLAYERS 134
TABLE 79 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION,
2023-2030 (USD MILLION) 135
TABLE 80 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 81 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,
BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 82 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLE MARKET FOR ASSAY KITS,
BY COUNTRY, 2023-2030 (USD MILLION) 136
TABLE 83 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,
BY COUNTRY, 2023-2030 (USD MILLION) 137
TABLE 84 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS,
BY REGION, 2023-2030 (USD MILLION) 137
TABLE 85 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION) 137
TABLE 86 MEDIA OFFERED BY KEY MARKET PLAYERS 138
TABLE 87 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION,
2023-2030 (USD MILLION) 138
TABLE 88 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,
BY COUNTRY, 2023-2030 (USD MILLION) 139
TABLE 89 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023-2030 (USD MILLION) 139
TABLE 90 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,
BY COUNTRY, 2023-2030 (USD MILLION) 140
TABLE 91 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,
BY COUNTRY, 2023-2030 (USD MILLION) 140
TABLE 92 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA,
BY REGION, 2023-2030 (USD MILLION) 140
TABLE 93 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLE MARKET FOR MEDIA,
BY COUNTRY, 2023-2030 (USD MILLION) 141
TABLE 94 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS 142
TABLE 95 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION,
2023-2030 (USD MILLION) 142
TABLE 96 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 142
TABLE 97 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 143
TABLE 98 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 143
TABLE 99 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 144
TABLE 100 MIDDLE EAST: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION) 144
TABLE 101 GCC COUNTRIES: OTHER LIVE CELL IMAGING CONSUMABLES MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 144
TABLE 102 SOFTWARE OFFERED BY KEY MARKET PLAYERS 145
TABLE 103 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION) 146
TABLE 104 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 146
TABLE 105 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 147
TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 147
TABLE 107 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 148
TABLE 108 MIDDLE EAST: LIVE CELL IMAGING SOFTWARE MARKET, BY REGION,
2023-2030 (USD MILLION) 148
TABLE 109 GCC COUNTRIES: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 148
TABLE 110 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION) 149
TABLE 111 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 149
TABLE 112 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 150
TABLE 113 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 150
TABLE 114 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 151
TABLE 115 MIDDLE EAST: LIVE CELL IMAGING SERVICES MARKET, BY REGION,
2023-2030 (USD MILLION) 151
TABLE 116 GCC COUNTRIES: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 151
TABLE 117 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 153
TABLE 118 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION,
2023-2030 (USD MILLION) 154
TABLE 119 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY COUNTRY, 2023-2030 (USD MILLION) 154
TABLE 120 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY COUNTRY, 2023-2030 (USD MILLION) 155
TABLE 121 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY COUNTRY, 2023-2030 (USD MILLION) 155
TABLE 122 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY COUNTRY, 2023-2030 (USD MILLION) 156
TABLE 123 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY,
BY REGION, 2023-2030 (USD MILLION) 156
TABLE 124 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 156
TABLE 125 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY REGION, 2023-2030 (USD MILLION) 157
TABLE 126 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 127 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 128 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 159
TABLE 129 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 159
TABLE 130 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY REGION, 2023-2030 (USD MILLION) 159
TABLE 131 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 160
TABLE 132 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY REGION, 2023-2030 (USD MILLION) 161
TABLE 133 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 161
TABLE 134 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 162
TABLE 135 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 162
TABLE 136 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 163
TABLE 137 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY REGION, 2023-2030 (USD MILLION) 163
TABLE 138 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 163
TABLE 139 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION,
2023-2030 (USD MILLION) 164
TABLE 140 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023-2030 (USD MILLION) 165
TABLE 141 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,
BY COUNTRY, 2023-2030 (USD MILLION) 165
TABLE 142 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,
BY COUNTRY, 2023-2030 (USD MILLION) 166
TABLE 143 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,
BY COUNTRY, 2023-2030 (USD MILLION) 166
TABLE 144 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING,
BY REGION, 2023-2030 (USD MILLION) 166
TABLE 145 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023-2030 (USD MILLION) 167
TABLE 146 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2023-2030 (USD MILLION) 168
TABLE 147 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION) 168
TABLE 148 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023-2030 (USD MILLION) 169
TABLE 149 ASIA PACIFIC: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 169
TABLE 150 LATIN AMERICA: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 170
TABLE 151 MIDDLE EAST: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION) 170
TABLE 152 GCC COUNTRIES: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET,
BY COUNTRY, 2023-2030 (USD MILLION) 170
TABLE 153 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 172
TABLE 154 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY REGION,
2023-2030 (USD MILLION) 173
TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 173
TABLE 156 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 174
TABLE 157 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 174
TABLE 158 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 175
TABLE 159 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY REGION, 2023-2030 (USD MILLION) 175
TABLE 160 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 175
TABLE 161 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION,
2023-2030 (USD MILLION) 176
TABLE 162 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2023-2030 (USD MILLION) 177
TABLE 163 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION) 177
TABLE 164 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION) 178
TABLE 165 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2023-2030 (USD MILLION) 178
TABLE 166 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION, 2023-2030 (USD MILLION) 178
TABLE 167 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2023-2030 (USD MILLION) 179
TABLE 168 LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY REGION,
2023-2030 (USD MILLION) 180
TABLE 169 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 180
TABLE 170 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION) 181
TABLE 171 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 181
TABLE 172 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 182
TABLE 173 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY REGION, 2023-2030 (USD MILLION) 182
TABLE 174 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2023-2030 (USD MILLION) 182
TABLE 175 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION,
2023-2030 (USD MILLION) 183
TABLE 176 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 184
TABLE 177 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 184
TABLE 178 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 185
TABLE 179 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 185
TABLE 180 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY REGION, 2023-2030 (USD MILLION) 185
TABLE 181 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 186
TABLE 182 LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 188
TABLE 183 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION) 189
TABLE 184 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 189
TABLE 185 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 190
TABLE 186 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 190
TABLE 187 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 191
TABLE 188 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION) 191
TABLE 189 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 191
TABLE 190 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2023-2030 (USD MILLION) 192
TABLE 191 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 193
TABLE 192 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 193
TABLE 193 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 194
TABLE 194 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 194
TABLE 195 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 194
TABLE 196 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 195
TABLE 197 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2023-2030 (USD MILLION) 196
TABLE 198 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 196
TABLE 199 EUROPE: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 197
TABLE 200 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 197
TABLE 201 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 198
TABLE 202 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION) 198
TABLE 203 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 198
TABLE 204 LIVE CELL IMAGING MARKET, BY REGION, 2023-2030 (USD MILLION) 200
TABLE 205 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 202
TABLE 206 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 203
TABLE 207 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 203
TABLE 208 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 203
TABLE 209 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 204
TABLE 210 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 204
TABLE 211 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 205
TABLE 212 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 205
TABLE 213 US: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 206
TABLE 214 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 206
TABLE 215 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 207
TABLE 216 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 207
TABLE 217 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 208
TABLE 218 US: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 208
TABLE 219 CANADA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 209
TABLE 220 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 209
TABLE 221 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 210
TABLE 222 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 210
TABLE 223 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 211
TABLE 224 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 211
TABLE 225 EUROPE: KEY MACROECONOMIC INDICATORS 212
TABLE 226 EUROPE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 213
TABLE 227 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 213
TABLE 228 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 213
TABLE 229 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 214
TABLE 230 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 214
TABLE 231 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 214
TABLE 232 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 215
TABLE 233 GERMANY: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 216
TABLE 234 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 216
TABLE 235 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 216
TABLE 236 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 217
TABLE 237 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 217
TABLE 238 GERMANY: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 217
TABLE 239 UK: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 218
TABLE 240 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 219
TABLE 241 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 219
TABLE 242 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 219
TABLE 243 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 220
TABLE 244 UK: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 220
TABLE 245 FRANCE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 221
TABLE 246 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 221
TABLE 247 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 222
TABLE 248 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 222
TABLE 249 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 223
TABLE 250 FRANCE: LIVE CEL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 223
TABLE 251 ITALY: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 224
TABLE 252 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 224
TABLE 253 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 224
TABLE 254 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 225
TABLE 255 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 225
TABLE 256 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 225
TABLE 257 SPAIN: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 226
TABLE 258 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 226
TABLE 259 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 227
TABLE 260 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 227
TABLE 261 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 228
TABLE 262 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 228
TABLE 263 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 229
TABLE 264 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 229
TABLE 265 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 230
TABLE 266 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 230
TABLE 267 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 231
TABLE 268 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 231
TABLE 269 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 233
TABLE 270 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 235
TABLE 271 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 235
TABLE 272 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 235
TABLE 273 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 236
TABLE 274 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 236
TABLE 275 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 237
TABLE 276 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 237

TABLE 277 CHINA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 238
TABLE 278 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 238
TABLE 279 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 239
TABLE 280 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 239
TABLE 281 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 240
TABLE 282 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 240
TABLE 283 JAPAN: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 241
TABLE 284 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 242
TABLE 285 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 242
TABLE 286 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 242
TABLE 287 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 243
TABLE 288 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 243
TABLE 289 INDIA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 244
TABLE 290 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 244
TABLE 291 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 245
TABLE 292 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 245
TABLE 293 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 246
TABLE 294 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 246
TABLE 295 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 247
TABLE 296 SOUTH KOREA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 248
TABLE 297 SOUTH KOREA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 248
TABLE 298 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 248
TABLE 299 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 249
TABLE 300 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 249
TABLE 301 AUSTRALIA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 250
TABLE 302 AUSTRALIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 250
TABLE 303 AUSTRALIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 251
TABLE 304 AUSTRALIA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 251
TABLE 305 AUSTRALIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 252
TABLE 306 AUSTRALIA: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 252
TABLE 307 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 253
TABLE 308 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 253
TABLE 309 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION) 254
TABLE 310 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 254
TABLE 311 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 255
TABLE 312 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 255
TABLE 313 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 257
TABLE 314 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 257
TABLE 315 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 257
TABLE 316 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 258
TABLE 317 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 258
TABLE 318 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 259
TABLE 319 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 259
TABLE 320 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 259
TABLE 321 BRAZIL: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 260
TABLE 322 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 261
TABLE 323 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 261
TABLE 324 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 261
TABLE 325 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 262
TABLE 326 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 262
TABLE 327 MEXICO: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 263
TABLE 328 MEXICO: LIVE CELL IMAGING INSTRUMENT MARKET, BY TYPE,
2023-2030 (USD MILLION) 263
TABLE 329 MEXICO: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 263
TABLE 330 MEXICO: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 264
TABLE 331 MEXICO: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 264
TABLE 332 MEXICO: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 264
TABLE 333 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 265
TABLE 334 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 265
TABLE 335 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION) 266
TABLE 336 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 266
TABLE 337 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 267
TABLE 338 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 267
TABLE 339 MIDDLE EAST: KEY MACROECONOMIC INDICATORS 269
TABLE 340 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 269
TABLE 341 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 269
TABLE 342 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 270
TABLE 343 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 270
TABLE 344 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 271
TABLE 345 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 271
TABLE 346 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY REGION,
2023-2030 (USD MILLION) 271
TABLE 347 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 272
TABLE 348 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 272
TABLE 349 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 273
TABLE 350 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 273
TABLE 351 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 274
TABLE 352 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 274
TABLE 353 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 275
TABLE 354 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 275
TABLE 355 SAUDI ARABIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 276
TABLE 356 SAUDI ARABIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 276
TABLE 357 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 277
TABLE 358 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 277
TABLE 359 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 278
TABLE 360 UAE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 278
TABLE 361 UAE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 279
TABLE 362 UAE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 279
TABLE 363 UAE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 279
TABLE 364 UAE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 280
TABLE 365 UAE: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 280
TABLE 366 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 281
TABLE 367 REST OF GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 281
TABLE 368 REST OF GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION) 281
TABLE 369 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 282
TABLE 370 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 282
TABLE 371 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 283
TABLE 372 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY OFFERING,
2023-2030 (USD MILLION) 283
TABLE 373 REST OF MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION) 284
TABLE 374 REST OF MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION) 284
TABLE 375 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 285
TABLE 376 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 285
TABLE 377 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY END USER,
2023-2030 (USD MILLION) 286
TABLE 378 AFRICA: KEY MACROECONOMIC INDICATORS 287
TABLE 379 AFRICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION) 287
TABLE 380 AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,
2023-2030 (USD MILLION) 288
TABLE 381 AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,
2023-2030 (USD MILLION) 288
TABLE 382 AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 288
TABLE 383 AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 289
TABLE 384 AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION) 289
TABLE 385 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN LIVE CELL IMAGING MARKET, 2022-2025 291
TABLE 386 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION 295
TABLE 387 LIVE CELL IMAGING MARKET: REGION FOOTPRINT 302
TABLE 388 LIVE CELL IMAGING MARKET: OFFERING FOOTPRINT 303
TABLE 389 LIVE CELL IMAGING MARKET: APPLICATION FOOTPRINT 305
TABLE 390 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 308
TABLE 391 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 309
TABLE 392 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES AND UPGRADES,
JANUARY 2022-APRIL 2025 310
TABLE 393 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2022-APRIL 2025 311
TABLE 394 LIVE CELL IMAGING MARKET: EXPANSIONS, JANUARY 2022-APRIL 2025 312
TABLE 395 DANAHER: COMPANY OVERVIEW 313
TABLE 396 DANAHER: PRODUCTS OFFERED 314
TABLE 397 DANAHER: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-APRIL 2025 316
TABLE 398 DANAHER: DEALS, JANUARY 2022-APRIL 2025 316
TABLE 399 ZEISS GROUP: COMPANY OVERVIEW 318
TABLE 400 ZEISS GROUP: PRODUCTS OFFERED 319
TABLE 401 ZEISS GROUP: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-APRIL 2025 320
TABLE 402 ZEISS GROUP: DEALS, JANUARY 2022-APRIL 2025 321
TABLE 403 ZEISS GROUP: EXPANSIONS, JANUARY 2022-APRIL 2025 321
TABLE 404 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 323
TABLE 405 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 324
TABLE 406 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-APRIL 2025 325
TABLE 407 REVVITY: COMPANY OVERVIEW 327
TABLE 408 REVVITY: PRODUCTS OFFERED 328
TABLE 409 REVVITY: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-APRIL 2025 329
TABLE 410 SARTORIUS AG: COMPANY OVERVIEW 331
TABLE 411 SARTORIUS AG: PRODUCTS OFFERED 332
TABLE 412 SARTORIUS AG: DEALS, JANUARY 2022-APRIL 2025 333
TABLE 413 NIKON CORPORATION: COMPANY OVERVIEW 334
TABLE 414 NIKON CORPORATION: PRODUCTS OFFERED 335
TABLE 415 NIKON CORPORATION: EXPANSIONS, JANUARY 2022-APRIL 2025 336
TABLE 416 EVIDENT: COMPANY OVERVIEW 337
TABLE 417 EVIDENT: PRODUCTS OFFERED 337
TABLE 418 EVIDENT: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022- APRIL 2025 338
TABLE 419 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 339
TABLE 420 AGILENT TECHNOLOGIES, INC: PRODUCTS OFFERED 340
TABLE 421 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES AND UPGRADES,
JANUARY 2022-APRIL 2025 342
TABLE 422 NANOENTEK: COMPANY OVERVIEW 343
TABLE 423 NANOENTEK INC.: PRODUCTS OFFERED 343
TABLE 424 BRUKER: COMPANY OVERVIEW 344
TABLE 425 BRUKER: PRODUCTS OFFERED 345
TABLE 426 BRUKER: DEALS, JANUARY 2022-APRIL 2025 346
TABLE 427 BD: COMPANY OVERVIEW 347
TABLE 428 BD: PRODUCTS OFFERED 348
TABLE 429 MERCK KGAA: COMPANY OVERVIEW 349
TABLE 430 MERCK KGAA: PRODUCTS OFFERED 351
TABLE 431 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 352
TABLE 432 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 353
TABLE 433 TECAN TRADING AG: COMPANY OVERVIEW 354
TABLE 434 TECAN TRADING AG: PRODUCTS OFFERED 355
TABLE 435 SYSMEX CORPORATION: COMPANY OVERVIEW 356
TABLE 436 SYSMEX CORPORATION: PRODUCTS OFFERED 357
TABLE 437 CORNING INCORPORATED: COMPANY OVERVIEW 358
TABLE 438 CORNING INCORPORATED: PRODUCTS OFFERED 359
TABLE 439 AXION BIOSYSTEMS, INC.: COMPANY OVERVIEW 360
TABLE 440 BLUE-RAY BIOTECH CORP.: COMPANY OVERVIEW 361
TABLE 441 CURIOSIS INC.: COMPANY OVERVIEW 361
TABLE 442 CYTENA GMBH: COMPANY OVERVIEW 362
TABLE 443 ABBERIOR GMBH: COMPANY OVERVIEW 363
TABLE 444 PHASE HOLOGRAPHIC IMAGING PHI AB: COMPANY OVERVIEW 364
TABLE 445 ALIGNED GENETICS INC.: COMPANY OVERVIEW 365
TABLE 446 CHERRY BIOTECH: COMPANY OVERVIEW 365
TABLE 447 NANOLIVE SA: COMPANY OVERVIEW 366
TABLE 448 CYTOTRONICS: COMPANY OVERVIEW 367
TABLE 449 ETALUMA, INC.: COMPANY OVERVIEW 368
TABLE 450 TISSUEGNOSTICS GMBH: COMPANY OVERVIEW 369

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4950.00
  • $6650.00
  • $8150.00
  • $10000.00
  • ADD TO BASKET
  • BUY NOW